Preeclampsia is a complex cardiovascular disorder of pregnancy with underlying
multifactorial pathogeneses; however, its etiology is not fully understood. It is characterized …

Preeclampsia, defined as new-onset hypertension accompanied by proteinuria occurring at
20 weeks of gestation or later, is a leading cause of perinatal morbidity and mortality …

Preeclampsia (PE) manifested by hypertension and proteinuria complicates 3% to 8% of
pregnancies and is a leading cause of fetal–maternal morbidity and mortality worldwide. It …

Preeclampsia is a pregnancy-specific disorder, of which one of its major subtypes, the
placental subtype is considered a response to an ischemic placental environment, impacting …

Preeclampsia (PE) affects 5% to 7% of pregnant women each year worldwide, accounts for
up to 18% of maternal deaths in the United States each year, and is the number 1 cause of …

Preeclampsia is associated with hypertension and increased infant and maternal morbidity
and mortality. The underlying cause of preeclampsia is largely unknown, but it is clear that …

Preeclampsia is a hypertensive disorder of major concern in pregnancy than can lead to
intrauterine growth restriction, placental abruption and stillbirth. The pathophysiology of …

Successful pregnancy relies on maternal immunologic tolerance mechanisms limit
maladaptive immune responses against the semi-allogeneic fetus and placenta and support …

Pre‐eclampsia (PE) is a leading cause of maternal and perinatal morbidity and mortality;
however, the aetiology of PE still remains unclear. It has been widely accepted that the …

Preeclampsia (PE) is one of the leading causes of maternal morbidity and mortality
worldwide. This disease is believed to occur in two stages with placental dysfunction in early …